FBXL4

F-box and leucine rich repeat protein 4, the group of F-box and leucine rich repeat proteins

Basic information

Region (hg38): 6:98868535-98948006

Links

ENSG00000112234NCBI:26235OMIM:605654HGNC:13601Uniprot:Q9UKA2AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • mitochondrial DNA depletion syndrome 13 (Supportive), mode of inheritance: AR
  • Leigh syndrome (Definitive), mode of inheritance: AR
  • mitochondrial DNA depletion syndrome 13 (Strong), mode of inheritance: AR
  • mitochondrial DNA depletion syndrome 13 (Strong), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Mitochondrial DNA depletion syndrome 13ARGeneralGenetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testingBiochemical; Craniofacial; Neurologic; Ophthalmologic23993193; 23993194

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the FBXL4 gene.

  • Mitochondrial DNA depletion syndrome 13 (19 variants)
  • not provided (11 variants)
  • Inborn genetic diseases (4 variants)
  • Mitochondrial DNA depletion syndrome (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the FBXL4 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
45
clinvar
36
clinvar
4
clinvar
85
missense
23
clinvar
253
clinvar
1
clinvar
277
nonsense
11
clinvar
9
clinvar
20
start loss
1
clinvar
1
frameshift
9
clinvar
9
clinvar
2
clinvar
20
inframe indel
2
clinvar
1
clinvar
3
splice donor/acceptor (+/-2bp)
2
clinvar
2
clinvar
4
splice region
2
1
10
5
18
non coding
21
clinvar
27
clinvar
13
clinvar
61
Total 22 45 323 63 18

Highest pathogenic variant AF is 0.000144

Variants in FBXL4

This is a list of pathogenic ClinVar variants found in the FBXL4 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
6-98874188-C-G Likely benign (Nov 09, 2018)1181505
6-98874260-T-C Mitochondrial DNA depletion syndrome 13 Uncertain significance (Aug 10, 2017)437825
6-98874267-C-T Mitochondrial DNA depletion syndrome 13 Uncertain significance (Aug 10, 2017)437824
6-98874269-T-C Mitochondrial DNA depletion syndrome 13 Conflicting classifications of pathogenicity (May 23, 2023)437827
6-98874273-T-C Mitochondrial DNA depletion syndrome 13 • FBXL4-related disorder Benign (Feb 04, 2020)437826
6-98874273-TTA-CTG Mitochondrial DNA depletion syndrome 13 Uncertain significance (Aug 10, 2017)437828
6-98874274-T-C Mitochondrial DNA depletion syndrome 13 Uncertain significance (Aug 10, 2017)437823
6-98874275-A-G not specified • Mitochondrial DNA depletion syndrome 13 Benign (Nov 22, 2023)381422
6-98874285-G-C Mitochondrial DNA depletion syndrome 13 Uncertain significance (Aug 10, 2017)437822
6-98874290-GCT-G Uncertain significance (Jun 13, 2022)2413614
6-98874298-T-C Uncertain significance (Mar 29, 2022)2119332
6-98874306-A-T Mitochondrial DNA depletion syndrome 13 Likely pathogenic (Aug 10, 2017)437487
6-98874307-C-G Inborn genetic diseases Uncertain significance (Feb 17, 2023)2486760
6-98874307-CT-C Mitochondrial DNA depletion syndrome 13 Likely pathogenic (Aug 10, 2017)437821
6-98874313-G-C Uncertain significance (Aug 27, 2021)1513827
6-98874318-C-T Mitochondrial DNA depletion syndrome 13 Uncertain significance (Aug 01, 2022)437820
6-98874348-T-C Mitochondrial DNA depletion syndrome 13 Uncertain significance (Aug 10, 2017)437819
6-98874354-T-G Mitochondrial DNA depletion syndrome 13 • not specified Conflicting classifications of pathogenicity (Mar 08, 2024)437486
6-98874356-C-A Mitochondrial DNA depletion syndrome 13 Uncertain significance (Aug 10, 2017)437817
6-98874356-C-T Mitochondrial DNA depletion syndrome 13 Conflicting classifications of pathogenicity (May 28, 2022)437818
6-98874356-CG-C Mitochondrial DNA depletion syndrome 13 Likely pathogenic (Feb 15, 2022)1341563
6-98874357-G-A Mitochondrial DNA depletion syndrome 13 Uncertain significance (Aug 20, 2022)437816
6-98874360-C-G Mitochondrial DNA depletion syndrome 13 Uncertain significance (Aug 31, 2022)1301609
6-98874365-G-A Mitochondrial DNA depletion syndrome 13 Uncertain significance (Aug 10, 2017)437815
6-98874366-G-C Mitochondrial DNA depletion syndrome 13 Uncertain significance (Aug 10, 2017)437814

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
FBXL4protein_codingprotein_codingENST00000369244 779430
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
1.14e-80.9341256600861257460.000342
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.5552993270.9140.00001614073
Missense in Polyphen82105.550.776911258
Synonymous-0.1011231221.010.000006011218
Loss of Function1.901727.80.6120.00000159315

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.001030.00102
Ashkenazi Jewish0.0002980.000298
East Asian0.0003810.000381
Finnish0.000.00
European (Non-Finnish)0.0004070.000404
Middle Eastern0.0003810.000381
South Asian0.00009800.0000980
Other0.0001640.000163

dbNSFP

Source: dbNSFP

Pathway
Post-translational protein modification;Metabolism of proteins;Immune System;Adaptive Immune System;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation;Neddylation (Consensus)

Recessive Scores

pRec
0.0992

Intolerance Scores

loftool
0.662
rvis_EVS
-0.93
rvis_percentile_EVS
9.55

Haploinsufficiency Scores

pHI
0.429
hipred
N
hipred_score
0.414
ghis
0.606

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
gene_indispensability_pred
E
gene_indispensability_score
0.647

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Fbxl4
Phenotype

Gene ontology

Biological process
protein polyubiquitination;ubiquitin-dependent protein catabolic process;SCF-dependent proteasomal ubiquitin-dependent protein catabolic process;post-translational protein modification
Cellular component
ubiquitin ligase complex;mitochondrial intermembrane space;cytosol;nuclear speck;SCF ubiquitin ligase complex
Molecular function
ubiquitin-protein transferase activity